United States and Global Poultry Diagnostics Market Segments and Growth by 2030

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030

United States and Global Poultry Diagnostics Market Size and Forecasts (2020 - 2030), Share, Trends, and Growth Opportunity Analysis - Report Coverage: By Test Type [Enzyme-Linked Immunosorbent Assay (ELISA) Tests, Polymerase Chain Reaction (PCR) Test, Hemagglutination-Inhibition (HI), and Others], Disease (Avian Salmonellosis, Avian Influenza, Newcastle Disease, Avian Mycoplasmosis, Infectious Bronchitis, and Others)

  • Report Date : Sep 2023
  • Report Code : TIPRE00031885
  • Category : Life Sciences
  • Status : Published
  • Available Report Formats : pdf-format excel-format
Page Updated: Dec 2023

Analyst Perspective:

The poultry diagnostics market in the US was valued at US$ XX thousand in 2022 and is projected to reach US$ XX thousand by 2030, growing at a CAGR of 10.2% during the forecast period. 

The US holds a significant share of the North America poultry diagnostics market. The US poultry industry is the world's largest producer of meat and eggs, second-largest poultry meat exporter, and a major egg producer. In the country, the consumption of poultry meat, including broilers, turkey, and other chicken, is significantly higher than beef or pork but less than total red meat consumption. Salmonella infections are extremely common. CDC estimates show that about 1.35 million infection cases, 26,500 hospitalizations, and 420 deaths are reported in the US every year due to Salmonella bacteria infection. Food is the source of most of these illnesses. After norovirus, salmonellosis is the second leading foodborne illness in the US and is the leading cause of hospitalizations and deaths from food poisoning.

According to White House officials, the Biden administration keeps a watchful eye on an eruption of avian influenza that has led to the deaths of 10 million of chickens, which increases the cost of eggs. The government is contemplating a mass vaccination campaign for poultry. As of July 5, 2022, the US Department of Agriculture (USDA) reported 40.09 million birds in 36 US states to be infected with highly pathogenic avian influenza (HPAI). Out of the 382 flocks that tested positive for the virus, 186 were commercial, and 196 were backyard flocks. Thus, the rising poultry disease incidence among poultry fuels the poultry diagnostics market growth in the US.

Market Segmentation - Poultry Diagnostics Market

SEGMENT NAME

TYPE

Test TypeEnzyme-Linked Immunosorbent Assay (ELISA) Tests, Polymerase Chain Reaction (PCR) Tests, Hemagglutination Inhibition (HI), Others
DiseaseAvian Influenza, Infectious Bronchitis, Avian Salmonellosis, Newcastle Disease, Avian Mycoplasmosis, Others


Poultry Diagnostics Market

  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Key Player Analysis - Poultry Diagnostics Market

  1. Thermo Fisher Scientific Inc
  2. Idexx Laboratories Inc 
  3. Qiagen NV 
  4. Eurofins Scientific SE
  5. IDVET 
  6. Boehringer Ingelheim International GmbH 
  7. Zoetis Inc
  8. BioCheck BV
  9. Bioneer Corp 
  10. BioInGenTech Biotechnologies

are the key Poultry Diagnostics Market players profiled in the report.

United States and Global Poultry Diagnostics Report Scope

Report Attribute Details
Market size in 2022 US$ XX thousand
Market Size by 2030 US$ XX thousand
Global CAGR (2022 - 2030) 10.2%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By Test Type
  • Enzyme-Linked Immunosorbent Assay Tests
  • Polymerase Chain Reaction Test
  • Hemagglutination-Inhibition
By Disease
  • Avian Salmonellosis
  • Avian Influenza
  • Newcastle Disease
  • Avian Mycoplasmosis
  • Infectious Bronchitis
Regions and Countries Covered United States
  • United States
Market leaders and key company profiles
  • Thermo Fisher Scientific Inc
  • Idexx Laboratories Inc
  • Qiagen NV
  • Eurofins Scientific SE
  • IDVET
  • Boehringer Ingelheim International GmbH
  • Zoetis Inc
  • BioCheck BV
  • Bioneer Corp
  • Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Identifying Emerging Markets
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Boosting Operational Efficiency
    • Strategic Planning
    • Investment Justification
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Our Clients
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo